Phibro Animal Health | PAHC - Assets


Phibro Animal Health reported $1.51B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Align Technology USD 6.52B 103.03M Sep/2026
ANI Pharmaceuticals USD 1.57B 73.55M Sep/2026
Aurora Cannabis CAD 620.88M 19.79M Jun/2026
Bristol-Myers Squibb USD 88.77B 1.14B Sep/2026
Canopy Growth CAD 1.1B 14.81M Jun/2026
Corcept Therapeutics USD 1.03B 145.32M Sep/2026
Eli Lilly USD 148.07B 5.79B Sep/2026
Henry Schein USD 11.51B 129M Sep/2026
Idexx Laboratories USD 3.71B 264.77M Sep/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Merck USD 132.77B 2.97B Sep/2026
Nektar Therapeutics USD 763.27M 482.86M Mar/2026
Pacira USD 34.68B 33.44B Sep/2026
Phibro Animal Health USD 1.51B 13.48M Sep/2026
Prestige Brands USD 4.72B 153.09M Sep/2026
Supernus Pharmaceuticals USD 1.4B 30.42M Sep/2026
Zoetis USD 15.09B 11M Sep/2026